HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.
EPN 2018

Robert J Goldberg

Robert J Goldberg, Speaker at Pediatrics Conferences
Robert J Goldberg
University of Massachusetts Medical School, United States


Dr. Robert J. Goldberg, Ph.D., is Professor and Chief, Division of Epidemiology of Chronic Diseases and Vulnerable Populations, in the Department of Quantitative Health Sciences at the University of Massachusetts Medical School. He is also Program Director of the medical school’s Masters of Science in Clinical Investigation (MSCI) Program. Dr. Goldberg has been actively involved in community-based studies of the natural history and primary and secondary prevention of coronary heart disease, heart failure, and deep venous thrombosis for more than three decades. He and several clinical researchers established the Worcester Heart Attack Study in the early 1980s. Through the current period of federal funding support, they are examining more than three-decade-long trends (1975-2007) in the incidence rates, in-hospital and long-term survival, and therapeutic approaches used in the management of more than 14,000 greater Worcester, Mass. residents hospitalized with acute myocardial infarction at all medical centers in the Worcester metropolitan area. He also presently serves as the Co-PI on a population-based surveillance project that is examining changing trends in the incidence, hospital and long-term case-fatality rates, and management practices of in and outpatients with venous thromboembolism among residents of the Worcester metropolitan area. He is also receiving funding support from the National Heart, Lung, and Blood Institute to develop community-wide hospital and outpatient surveillance for heart failure in greater Worcester residents. Dr. Goldberg serves as the senior epidemiologist for the Global Registry of Acute Coronary Events (GRACE) Project, which is a large multinational coronary disease registry examining differences in the management practices, hospital, and post-discharge outcomes of more than 50,000 patients hospitalized in 14 countries with an acute coronary syndrome.